Results 41 to 50 of about 39,531 (226)

RNA‐Binding Protein RBM25 Targets the mRNA Stability of GTPase Rab22a to Restrict Viral Entry and Infection

open access: yesAdvanced Science, EarlyView.
This study identifies RNA‐binding protein RBM25 as a broad‐spectrum antiviral factor acting independently of type I interferon. It blocks viral entry by suppressing GTPase Rab22a via the RC3H1‐mediated destabilization of Rab22a mRNA. Viral downregulation of RBM25 enhances GTPase Rab22a expression and viral entry, revealing an unreported post ...
Yingying Ding   +13 more
wiley   +1 more source

DENGUE EPIDEMIC APPREHENDED IN PAKISTAN: KNOWLEDGE AND PREVENTIVE MEASURES CAN AVERT IT

open access: yesGomal Journal of Medical Sciences, 2019
Dengue fever (DF) is a viral disease transmitted by Aedes aegypti and Aedes albopictus mosquitoes. Dengue virus (DENV) has four subtypes or serotypes i.e. DENV-1, DEVNV-2, DENV-3, and DENV-4.1,2 The incubation period is 3 to 14 days.
Habibullah Khan, Iftikhar Ahmad
doaj   +1 more source

Dengue and Other Viral Hemorrhagic Fevers

open access: yesIndian Journal of Critical Care Medicine, 2021
How to cite this article: Shastri PS, Taneja S. Dengue and Other Viral Hemorrhagic Fevers. Indian J Crit Care Med 2021;25(Suppl 2):S130-S133.
Shastri, Prakash S, Taneja, Saurabh
openaire   +3 more sources

Histidine Supplementation Stabilizes Hearing and Vision and Improves Growth in HARS1‐Related Autosomal Recessive Disorder Associated With Usher‐Like Symptoms

open access: yesAmerican Journal of Medical Genetics Part A, EarlyView.
ABSTRACT Autosomal recessive HARS1‐related disorder (originally described as Usher syndrome type 3B) caused by a homozygous Y454S variant in the histidyl‐tRNA synthetase gene (HARS1) is characterized by progressive sensorineural hearing and vision loss and respiratory deterioration with risk for sudden death following febrile illnesses.
Victoria Mok Siu   +23 more
wiley   +1 more source

Determination of serum adenosine deaminase and xanthine oxidase levels in patients with crimean-congo hemorrhagic fever

open access: yesClinics, 2010
OBJECTIVE: Crimean-Congo hemorrhagic fever is an acute viral hemorrhagic fever with a high mortality rate. Despite increasing knowledge about hemorrhagic fever viruses, little is known about the pathogenesis of Crimean-Congo hemorrhagic fever.
V. Kenan Celik   +5 more
doaj   +1 more source

A Prothrombotic Shift: Cerebral Venous Sinus Thrombosis in the Recovery Phase of Dengue Fever-A Case Report. [PDF]

open access: yesClin Case Rep
ABSTRACT Post‐dengue cerebral venous sinus thrombosis is an uncommon complication of dengue fever. It occurs due to a prothrombotic shift during the recovery or critical phase of dengue fever, presenting usually as a persistent headache. Prompt neuroimaging and anticoagulation are crucial to a favorable prognosis, even in the presence of hemorrhagic ...
Abedeen ZU   +5 more
europepmc   +2 more sources

Duck Orbivirus and Egg Production: A Newly Identified Duck Orbivirus Is the Etiological Agent of Egg Production Decline in Chinese Breeder Ducks

open access: yesAnimal Research and One Health, EarlyView.
Field samples from breeder duck farms with egg‐production decline were subjected to viral detection, genome sequencing, and virus isolation. Experimental infection demonstrated that duck orbivirus (DORV) causes a significant and persistent reduction in egg production in breeder ducks.
Bing Li   +18 more
wiley   +1 more source

The diagnostic challenge of pandemic H1N1 2009 virus in a dengue-endemic region: A case report of combined infection in Jeddah, Kingdom of Saudi Arabia

open access: yesJournal of Infection and Public Health, 2012
Summary: It is difficult to distinguish dengue fever from other febrile illnesses in a dengue-endemic area. This issue was compounded during the H1N1 2009 pandemic of influenza, which also presents as a febrile illness.
Raheela Hussain   +2 more
doaj   +1 more source

Inflammation Unchecked: Concurrent Kawasaki Disease and Stevens‐Johnson Syndrome in an 18‐Month‐Old Child

open access: yes
Arthritis Care &Research, EarlyView.
Catherine Deffendall   +6 more
wiley   +1 more source

Evaluating the (comparative) safety profile of the novel oral polio vaccine type 2 using individual case safety reports in VigiBase

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aim Novel oral polio vaccine type 2 (nOPV2) was used under the WHO emergency use listing for circulating vaccine‐derived polio virus (cVDPV) outbreaks from 2021 to 2023. We assessed nOPV2 adverse events following immunization (AEFIs) and compared its safety profile to other vaccines using VigiBase.
Comfort Kunak Ogar   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy